- recruitingPHASE3
A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
This study looks at a new medicine called mezagitamab for a kidney problem called IgA nephropathy. It compares mezagitamab to a dummy medicine to see if it lowers protein in the urine and helps protect kidneys. All adults over 18 with this condition can take part.
United States · Argentina · Australia - recruiting
A Study of Maribavir in Adults With Kidney Failure Who Have a Cytomegalovirus (CMV) Infection After Transplantation
This study looks at how safe a medicine called maribavir is for adults with serious kidney problems and a CMV germ infection after they've had an organ transplant. We're reviewing existing medical records to understand its effects without changing anyone's care.
Belgium · Estonia · France - recruitingPHASE1
A Study to Evaluate the Safety, Tolerability, and Effects on Blood and Urine Markers of Single Ascending Dose of GSK4771261 in Healthy Participants and Participants With Autosomal Dominant Polycystic Kidney Disease
This study is testing a new drug, GSK4771261, for kidney disease. It looks at how safe it is and what it does to the body in healthy people and those with a specific kidney condition called ADPKD.
Belgium · Canada · France - authorisedTherapeutic exploratory (Phase II)
A randomized controlled, two-arm (1:1 ratio) Phase IIa trial to assess the efficacy and safety of obinutuzumab in treating adults with de novo minimal change disease
This study is testing a new medicine called obinutuzumab for a kidney condition called minimal change disease. We want to see if it works as well as, or better than, current treatments, and if it's safe for adults.
Germany · Austria · France